In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Tenet Healthcare Corp (NYSE: THC) closed at $196.33 in the last session, up 3.33% from day before closing price of $190.0. In other words, the price has increased by $3.33 from its previous closing price. On the day, 1.18 million shares were traded. THC stock price reached its highest trading level at $196.58 during the session, while it also had its lowest trading level at $190.68.
Ratios:
We take a closer look at THC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.17. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.51 whereas as Long-Term Debt/Eq ratio is at 3.49.
Wells Fargo Upgraded its Equal Weight to Overweight on May 29, 2025, while the target price for the stock was maintained at $195.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 10 ’25 when Sutaria Saumya sold 78,762 shares for $190.78 per share. The transaction valued at 15,026,139 led to the insider holds 368,683 shares of the business.
Sutaria Saumya bought 78,762 shares of THC for $15,025,892 on Sep 10 ’25. On Aug 28 ’25, another insider, Lynch Christopher S., who serves as the Director of the company, sold 8 shares for $183.44 each. As a result, the insider received 1,468 and left with 12,350 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 17345951744 and an Enterprise Value of 32448952320. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.57, and their Forward P/E ratio for the next fiscal year is 12.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 4.63. Its current Enterprise Value per Revenue stands at 1.569 whereas that against EBITDA is 7.489.
Stock Price History:
The Beta on a monthly basis for THC is 1.54, which has changed by 0.19691515 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $207.14, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is 5.18%, while the 200-Day Moving Average is calculated to be 26.34%.
Shares Statistics:
According to the various share statistics, THC traded on average about 1.26M shares per day over the past 3-months and 866560 shares per day over the past 10 days. A total of 88.34M shares are outstanding, with a floating share count of 87.27M. Insiders hold about 1.22% of the company’s shares, while institutions hold 98.36% stake in the company. Shares short for THC as of 1759190400 were 2466616 with a Short Ratio of 1.96, compared to 1756425600 on 2343338. Therefore, it implies a Short% of Shares Outstanding of 2466616 and a Short% of Float of 3.75.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.75. . The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
Currently, 18.0 analysts are dedicated to thoroughly evaluating and rating the performance of Tenet Healthcare Corp (THC) in the stock market.The consensus estimate for the next quarter is $4.09, with high estimates of $4.36 and low estimates of $3.69.
Analysts are recommending an EPS of between $16.35 and $14.99 for the fiscal current year, implying an average EPS of $15.82. EPS for the following year is $15.99, with 20.0 analysts recommending between $17.77 and $13.51.
Revenue Estimates
According to 16 analysts, . The current quarter’s revenue is expected to be $5.26B. It ranges from a high estimate of $5.35B to a low estimate of $5.19B. As of . The current estimate, Tenet Healthcare Corp’s year-ago sales were $5.12BFor the next quarter, 16 analysts are estimating revenue of $5.37B. There is a high estimate of $5.49B for the next quarter, whereas the lowest estimate is $5.21B.
A total of 18 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.41B, while the lowest revenue estimate was $21.05B, resulting in an average revenue estimate of $21.15B. In the same quarter a year ago, actual revenue was $20.66BBased on 19 analysts’ estimates, the company’s revenue will be $22.03B in the next fiscal year. The high estimate is $22.47B and the low estimate is $21.51B.
